Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christof Rass"'
Autor:
Thomas Melchardt, Stefanie Jilg, Philipp J Jost, Florian Huemer, Bettina Jansko, Theresa Magnes, Eckhard Klieser, Richard Greil, Christof Rass, Lisa Pleyer, Alexander Egle, Sigrun Greil-Ressler, Adam Wahida, Katja Steiger
Publikováno v:
Kompass Onkologie. 7:107-110
Die akute myeloische Leukämie (AML) ist eine Erkrankung, die vor allem ältere Menschen betrifft, und die Überlebenschancen nach Versagen von hypomethylierenden Wirkstoffen (hypomethylating agents, HMAs) sind nach wie vor gering. Der BCL-2-Inhibito
Autor:
Stefanie Jilg, Teresa Magnes, Richard Greil, Alexander Egle, Thomas Melchardt, Florian Huemer, Adam Wahida, Philipp J. Jost, Lisa Pleyer, Sigrun Greil-Ressler, Eckhard Klieser, Katja Steiger, Bettina Jansko, Christof Rass
Publikováno v:
European Journal of Haematology
Acute myeloid leukemia (AML) is a disease of the elderly population and survival remains poor after failure of hypomethylating agents (HMA). The BCL-2 inhibitor venetoclax demonstrated activity as monotherapy and in combination with chemotherapy or H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fcb9a62c09ebf54331c9520e46b1ba8
https://mediatum.ub.tum.de/1538487
https://mediatum.ub.tum.de/1538487
Autor:
Michael A. Fridrik, Christof Rass, Renate Schabel-Moser, Johannes Andel, Martin Moik, Gudrun Russ, Richard Greil, Brigitte Mlineritsch, Peter Mayer
Publikováno v:
Oncology Research and Treatment. 32:18-24
This multicenter phase II trial was conducted to analyze the clinical activity and toxicity of the combination of pegylated liposomal doxorubicin and vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.From August 20
Autor:
Peter Mayer, G. Vesenmayer, Gudrun Russ, W Oberaigner, E Reiter, Hubert Hausmaninger, Christof Rass, Brigitte Mlineritsch
Publikováno v:
Onkologie. 27(5)
OBJECTIVES Aim of this study was to evaluate the clinical benefit and the toxicity of pegylated liposomal doxorubicin. PATIENTS AND METHODS Patients with metastatic breast cancer (n = 30) who failed a prior chemotherapy regimen for metastatic disease
Autor:
Werner Hohenberger, Gudrun Russ, Richard Greil, Andreas Kirschniak, M. Voigt, Chung-Bao Hsieh, Quan-Yang Duh, Annika Siegmund, Rainer Kube, Luciano Wannesson, Derek Zieker, R. Oberhoffer, Hans Lippert, S. Pildner von Steinburg, Henry Ptok, Christian Peschel, Luca Mazzucchelli, Kathrin Abbrederis, H. Menzel, Ingo Gastinger, Stefan Löb, Ingmar Königsrainer, Florian Lordick, Heng-Sheng Li, Rabea Thom, Solveig Horstmann, Ekaterina Chigrinova, Jawaher Ansari, Michael A. Fridrik, Björn L.D.M. Brücher, Chih-Feng Chien, Jonas Göhl, Tibor Schuster, E. Ostermayer, Martin Moik, Ming-Lang Shih, K.T.M. Schneider, Peter Mayer, Sylvie Lorenzen, Joerg T. Hartmann, Thomas Kratt, Anne K. Baumgärtner, Kuo-Feng Hsu, N Rothling, Christoph Kahlert, Dirk Jäger, Renate Schabel-Moser, Arfeen Fatima, Jiri Dolezal, Shalini Chaudhri, Michael Wallace, Angela Ihbe-Heffinger, Johannes Andel, Michele Ghielmini, Rupesh I. Bhatt, Leonidas Apostolidis, Jørn Herrstedt, Alfred Königsrainer, Christof Rass, Nicholas D. James, Volker R. Jacobs, Brigitte Mlineritsch, Susanne Merkel, Mariana Raditchkova, Claudius Falch, Stefan Beckert, Stefanie Wolff
Publikováno v:
Oncology Research and Treatment. 32:62-62